NCT07342530

Brief Summary

The purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Mar 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Mar 2026Dec 2027

First Submitted

Initial submission to the registry

January 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 9, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

April 24, 2026

Status Verified

February 1, 2026

Enrollment Period

1.7 years

First QC Date

January 9, 2026

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • Percentage of participants initiating assigned treatment

    Proportion of participants who begin their assigned intervention (≥1 session for WET; completion of initial training for CGRI)

    Baseline (up to 2 weeks)

  • Percentage of participants completing Written Exposure Therapy (WET)

    Baseline to Week 6

  • Percentage adherence to Written Exposure Therapy (WET)

    Baseline to Week 6

  • Percentage of participants completing Capnometry Guided Respiratory Intervention (CGRI)

    Baseline to Week 6

  • Percentage adherence to Capnometry Guided Respiratory Intervention (CGRI)

    Baseline to Week 6

  • Participant Satisfaction Scale Score using Client Satisfaction Questionnaire (CSQ-8)

    Participant satisfaction measured using the CSQ-8 questionaire, an 8-item scale. (Scale score 8 - 32. Higher scores represent greater satisfaction with treatment.)

    Week 5

  • Treatment credibility using the Opinion About Treatment (OAT) form

    Participant perceptions of treatment credibility will be measured using the OAT form. (Scale score 3 - 27. Higher scores represent greater perceived credibility of the intervention.)

    Week 5

Secondary Outcomes (15)

  • Change from baseline in PTSD Checklist for DSM-5 (PCL-5) Scale Score

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12

  • Change from baseline in Edinburgh Postnatal Depression Scale (EPDS) Scale Score

    Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12

  • Change from baseline in Whole Person Health Index (WPHI) Scale Score

    Baseline, Week 3, Week 6, Week 12

  • Change from baseline in Generalized Anxiety Disorder Questionaire (GAD-7)

    Baseline, Week 3, Week 6, Week 12

  • Change from baseline in Maternal-infant bonding (MIBS) Scale Score

    Baseline, Week 3, Week 6, Week 12

  • +10 more secondary outcomes

Study Arms (3)

Postpartum Standard of Care

NO INTERVENTION

Participants will follow their current standard of care.

Written Exposure Therapy (WET)

EXPERIMENTAL

Participants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.

Behavioral: Written Exposure Therapy (WET)

Capnometry-Guided Breathing Intervention (CGRI)

EXPERIMENTAL

Participants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.

Device: Capnometry-Guided Breathing Intervention (CGRI)

Interventions

Participants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.

Written Exposure Therapy (WET)

Participants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.

Also known as: Freespira
Capnometry-Guided Breathing Intervention (CGRI)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18
  • Delivered a live infant within 5 days
  • Severe maternal morbidity or infant admitted to NICU
  • PCL-5 ≥28
  • English-speaking
  • Able to consent and participate

You may not qualify if:

  • Active psychosis or mania
  • Current suicidal crisis
  • Current suicidal intent or plan
  • Cognitive impairment preventing participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

NOT YET RECRUITING

Stanford University

Palo Alto, California, 94304, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Pervez Sultan

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Debra Kaysen

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics)

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 15, 2026

Study Start

March 9, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

April 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 9 months and ending 36 months following article publication.
Access Criteria
Wish whom? Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For what types of analysis? For individual participant data meta-analysis By what mechanism will data be made available? Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at (Link to be provided).

Locations